Gam Holding Ag Myriad Genetics Inc Transaction History

Gam Holding Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 09, 2018	SELL	$27.75 - $40.17 $406,176 - $587,968	-14,637 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$28.83 - $41.01 $468,112 - $665,879	-16,237 Reduced 52.59%	14,637 $433,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $878,365 - $1.15 Million	30,874	30,874 $1.06 Million

232

92.6M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.